H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Get your full text copy in PDF

Assessment of the efficiency of interferon alpha in the treatment of the chronic hepatitis B in 1-5 year-old children

Mieczysława Czerwionka-Szaflarska, Anna Krenska-Wiˆącek, Anna Szaflarska-Szczepanik, Ewa Sobkowiak

Med Sci Monit 1998; 4(3): CR477-483

ID: 502460


The aim of the present study was to evaluate the treatment of chronic hepatitis B with interferon alpha in 1-5 year-old children. Interferon was administered subcutaneously, 3 times a week, in the dose of 3 mln units throughout 20 weeks (60 doses in total). As a result of the therapy, a HBsAg/antiHBs seroconversion was obtained in 51% of cases, the normalisation of A1AT activity - in 74%, and the remission in histopathological picture occurred in 47% of cases. The efficiency of the treatment seems to be even better in the youngest patients - up to 3rd year of life, as 'e' seroconversion was observed in 66%; of cases. Side effects that occurred in the course of the therapy were of short duration and did not require the discontinuation of the treatment.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree